ADVOCATE. CONNECT. INNOVATE.

Category Archives: Institute

FAST & Fellows Round Up

November 2017 Read the latest in FAST and Fellows news: Encellin’s (FAST Spring 2017) insulin-releasing implant for Type-1 Diabetes featured on NPR Read More LogicInk (FAST Spring 2017) announced their first product, LogicInk UV, an electronics-free temporary wearable powered by programmable ink Read More Eidos Therapeutics (FAST Spring 2016) initiates Phase 1 trial of AG10, … Continue reading FAST & Fellows Round Up

CARB-X Updates November 2017

Powered by CARB-X company Spero plans for $75M IPO for November 2nd (SPRO) Read More Inhibrx Wins CARB-X Award of up to $6.0M to Accelerate Development of its Novel Antibody, INBRX-111, to Treat Pseudomonas Infections Read More CARB-X backs Integrated Biotherapeutics to accelerate the development of a novel toxoid-based vaccine to prevent drug-resistant MRSA infections … Continue reading CARB-X Updates November 2017

CLSI Launches Innovation Series with Reimbursement Panel at Verily

October 24, 2017 The California Life Sciences Institute has launched a new Innovation Series that will focus on issues most pressing for life science startups from the very early to more advanced stage of development.  The inaugural session – Reimbursement 101 – took place on October 24 at Verily in South San Francisco and was sponsored … Continue reading CLSI Launches Innovation Series with Reimbursement Panel at Verily

CLSI Participates in Antimicrobial Resistance Panel at the 2017 BIO Investor Forum

  Heather Shane, Executive Director of the CLSI CARB-X accelerator, spoke at this year’s BIO Investor Forum in San Francisco at a panel on the Antimicrobial Resistance: New Research and Funding Opportunities. The panel sought to explore the growing threat of antimicrobial resistance (AMR), the economic challenges in developing these products, and the incentives proposed … Continue reading CLSI Participates in Antimicrobial Resistance Panel at the 2017 BIO Investor Forum

FAST & Fellows Round Up

October 2017 Read the latest in FAST and Fellows news: Current FAST Fall 2017 company Inflammatix, FAST Grads HepaTx (Spring 2017), X-Therma (Spring 2017), Empire Biotechnologies(Fall 2016), SciBac (Fall 2016), Eidos Therapeutics (Spring 2016), and Magnetic Insight (Spring 2015), presented at BIO Investor Forum in San Francisco. FAST Grad Eidos Therapeutics (Spring 2016) initiates Phase … Continue reading FAST & Fellows Round Up

CARB-X Updates

October 2017 Read the latest of CARB-X: CARB-X awarded its 20th project yesterday, funding Amicrobe to develop  a new bioengineered antimicrobial designed for direct application to contaminated and infected tissues Read More Powered By CARB-X company Microbiotix and the AMR Centre announce co-development agreement targeting drug resistant P.aeruginosa in critically ill pneumonia patients Read More … Continue reading CARB-X Updates

CLSI and SENS Research Foundation Launch Rejuvenation Biology Collaboration

On September 11, 2017, the California Life Sciences Institute (CLSI) and SENS Research Foundation (SRF) held the first “Rejuvenation Biotechnology Showcase” at the UCSF Mission Bay Conference Center with over 100 persons in attendance. The evening included a snapshot of technologies at SRF as well as presentations from four FAST graduate companies whose technologies hold … Continue reading CLSI and SENS Research Foundation Launch Rejuvenation Biology Collaboration

CARB-X Updates

September 2017 Read the latest of CARB-X: CARB-X publishes first annual report. Highlighting its pipeline of 18 promising research projects with 8 new classes of antibiotics to treat the most urgent drug-resistant gram-negative bacteria. Read More CARB-XED, GARDP, ASM, and ESCMID hosted Antibiotic Bootcamps at ASM-ESCMID conference on antibiotic R&D Read More CARB-X-funded Proteus IRC’s … Continue reading CARB-X Updates

FAST & Fellows Round Up

September 2017 Read the latest in FAST and Fellows news: GigaGen (FAST Spring 2015) studies published in peer-reviewed journal mAbs, on validating its novel monoclonal antibody discovery approach in mouse and human antibody repertoires Read More Former CLSA Fellow Alzeca, which is developing an imaging agent to help doctors detect Alzheimer’s disease at its earliest … Continue reading FAST & Fellows Round Up